Otsuka Wins Block On Cancer Drug Lonsurf's Generic Version
By Hannah Albarazi · August 16, 2023, 9:57 PM EDT
Otsuka Holdings Co. Ltd.'s Taiho unit nabbed a win Tuesday when a Delaware federal judge upheld its patent for the metastatic colorectal cancer drug treatment Lonsurf, likely keeping a generic version...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login